LEXX — Lexaria Bioscience Corp.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-01-12.
Performance
Technicals
Others in Healthcare
Measured signals that fired on LEXX
| date | signal | measured base rate |
|---|---|---|
| 2026-05-15 | Institutional holders jumped in a quarter ownership | -0.52% over 21 days · t = -0.38 · n = 1,553 not distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-03-17 | BUNKA CHRISTOPHER Director | Gift | 100.0K | 0.00 | 0 |
| 2025-07-30 | BUNKA CHRISTOPHER Director | Open-market purchase | 11.9K | 0.91 | 10.8K |
| 2025-07-29 | BUNKA CHRISTOPHER Director | Open-market purchase | 15.6K | 0.92 | 14.4K |
| 2025-07-29 | CHRISTOPHER RICHARD Chief Executive Officer | Open-market purchase | 15.0K | 0.91 | 13.7K |
| 2025-07-29 | DOCHERTY JOHN MARTIN President & CSO | Open-market purchase | 5.4K | 0.93 | 5.0K |
| 2025-07-29 | McKechnie William Edward Director | Open-market purchase | 5.0K | 0.91 | 4.5K |
| 2025-07-29 | Carle Vanessa Secretary | Open-market purchase | 750 | 0.91 | 682 |
| 2025-01-07 | BUNKA CHRISTOPHER Director | Grant or award | 100.0K | 0.00 | 0 |
| 2024-12-03 | CHRISTOPHER RICHARD Chief Executive Officer | Open-market purchase | 27.2K | 2.47 | 67.1K |
| 2024-12-02 | CHRISTOPHER RICHARD Chief Executive Officer | Open-market purchase | 22.8K | 2.24 | 51.1K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Invenomic Capital Management LP | 345.0K | 442.3K |
| GEODE CAPITAL MANAGEMENT, LLC | 229.5K | 294.2K |
| VANGUARD CAPITAL MANAGEMENT LLC | 173.4K | 222.3K |
| TORONTO DOMINION BANK | 109.3K | 140.0K |
| VANGUARD FIDUCIARY TRUST CO | 73.4K | 94.2K |
| UBS Group AG | 41.1K | 52.7K |
| STATE STREET CORP | 30.7K | 39.3K |
| BlackRock, Inc. | 21.4K | 27.4K |
| XTX Topco Ltd | 19.6K | 25.1K |
| Krilogy Financial LLC | 19.4K | 19.7K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-17 | 2026-08-17 | on EDGAR ↗ |
| 8-K | 2026-08-10 | 2026-08-04 | on EDGAR ↗ |
| 8-K | 2026-07-30 | 2026-07-29 | on EDGAR ↗ |
| 10-Q | 2026-07-13 | 2026-05-31 | on EDGAR ↗ |
| 10-Q | 2026-04-13 | 2026-02-28 | on EDGAR ↗ |
| 4 | 2026-03-18 | 2026-03-17 | on EDGAR ↗ |
| 8-K | 2026-02-06 | 2026-02-04 | on EDGAR ↗ |
| 8-K | 2026-01-28 | 2026-01-27 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Lexaria Bioscience Corp. (LEXX) filed form 8-K · 2026-08-17 · SEC EDGAR
- Lexaria Bioscience Corp. (LEXX) filed form 8-K · 2026-08-17 · SEC EDGAR
- Lexaria Bioscience Corp. (LEXX) filed form 8-K · 2026-08-10 · SEC EDGAR
Ask the AI about LEXX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →